Martinien Rula

Martinien Rula, CFA, joined Jefferies in July 2023 and has been covering EU MedTech companies for 3 years. James Vane-Tempest joined Jefferies in 2009 and has covered the healthcare sector for > 20 years, expanding into a wide range of subsectors which gives a unique perspective of the industry. In 2017, James was named #1 stock picker in the UK across all sectors in the Thomson Reuters Analyst Awards. Julien Dormois joined Jefferies in May 2023 to cover EU Medical Technologies companies. Julien has almost 20 years of experience covering MedTech across Europe, and his team consistently ranked Top 3 with pan-European investors for the last 12 years. Christopher Richardson, ACA, joined Jefferies in July 2024, having covered EU large cap pharma companies for 2 years prior and is a qualified chartered accountant.

What We Are Known For

• Breadth of coverage allows the team to bring a diverse range of often under-covered opportunities to investors. The team provides stock specific insights against a backdrop of extreme market volatility, subsector dynamics & expectation trends, and this year introduced a framework to assess share prices vs. sellside and buyside expectations.
• View from the Field and Expert series. Industry conferences and expert events where frontier sector issues are discussed by KOLs to provide insights and feedback on MedTech, Healthcare Services as well as wider Tools, Pharma Packaging and Specialty Pharma.
• Scenario & Divisional Analysis. We regularly provide sensitivities to earnings and valuation to core guidance assumptions as well as divisional valuation assessments.